Effect of exogenous estrogens and progestogens on the course of migraine during reproductive age: A consensus statement by the European Headache Federation (EHF) and the European Society of Contraception and Reproductive Health (ESCRH)

Simona Sacco, Gabriele S. Merki-Feld, Karen Lehrmann Ægidius, Johannes Bitzer, Marianne Canonico, Andreas R. Gantenbein, Tobias Kurth, Christian Lampl, Øjvind Lidegaard, E. Anne Macgregor, Antoinette Maassenvandenbrink, Dimos Dimitrios Mitsikostas, Rossella Elena Nappi, George Ntaios, Koen Paemeleire, Per Morten Sandset, Gisela Marie Terwindt, Kjersti Grøtta Vetvik, Paolo Martelletti

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

We systematically reviewed data about the effect of exogenous estrogens and progestogens on the course of migraine during reproductive age. Thereafter a consensus procedure among international experts was undertaken to develop statements to support clinical decision making, in terms of possible effects on migraine course of exogenous estrogens and progestogens and on possible treatment of headache associated with the use or with the withdrawal of hormones. Overall, quality of current evidence is low. Recommendations are provided for all the compounds with available evidence including the conventional 21/7 combined hormonal contraception, the desogestrel only oral pill, combined oral contraceptives with shortened pill-free interval, combined oral contraceptives with estradiol supplementation during the pill-free interval, extended regimen of combined hormonal contraceptive with pill or patch, combined hormonal contraceptive vaginal ring, transdermal estradiol supplementation with gel, transdermal estradiol supplementation with patch, subcutaneous estrogen implant with cyclical oral progestogen. As the quality of available data is poor, further research is needed on this topic to improve the knowledge about the use of estrogens and progestogens in women with migraine. There is a need for better management of headaches related to the use of hormones or their withdrawal.

Original languageEnglish
Article number76
JournalJournal of Headache and Pain
Volume19
Issue number1
DOIs
Publication statusPublished - Aug 31 2018

Fingerprint

Reproductive Health
Progestins
Migraine Disorders
Headache
Estrogens
Contraceptives, Oral, Combined
Estradiol
Contraceptive Agents
Desogestrel
Female Contraceptive Devices
Hormones
Contraception
Gels
Research
Therapeutics

Keywords

  • Contraception
  • Estrogens
  • Headache
  • Hormonal contraceptives
  • Migraine
  • Progestogens

ASJC Scopus subject areas

  • Clinical Neurology
  • Anesthesiology and Pain Medicine

Cite this

Effect of exogenous estrogens and progestogens on the course of migraine during reproductive age : A consensus statement by the European Headache Federation (EHF) and the European Society of Contraception and Reproductive Health (ESCRH). / Sacco, Simona; Merki-Feld, Gabriele S.; Ægidius, Karen Lehrmann; Bitzer, Johannes; Canonico, Marianne; Gantenbein, Andreas R.; Kurth, Tobias; Lampl, Christian; Lidegaard, Øjvind; Anne Macgregor, E.; Maassenvandenbrink, Antoinette; Mitsikostas, Dimos Dimitrios; Nappi, Rossella Elena; Ntaios, George; Paemeleire, Koen; Sandset, Per Morten; Terwindt, Gisela Marie; Vetvik, Kjersti Grøtta; Martelletti, Paolo.

In: Journal of Headache and Pain, Vol. 19, No. 1, 76, 31.08.2018.

Research output: Contribution to journalArticle

Sacco, S, Merki-Feld, GS, Ægidius, KL, Bitzer, J, Canonico, M, Gantenbein, AR, Kurth, T, Lampl, C, Lidegaard, Ø, Anne Macgregor, E, Maassenvandenbrink, A, Mitsikostas, DD, Nappi, RE, Ntaios, G, Paemeleire, K, Sandset, PM, Terwindt, GM, Vetvik, KG & Martelletti, P 2018, 'Effect of exogenous estrogens and progestogens on the course of migraine during reproductive age: A consensus statement by the European Headache Federation (EHF) and the European Society of Contraception and Reproductive Health (ESCRH)', Journal of Headache and Pain, vol. 19, no. 1, 76. https://doi.org/10.1186/s10194-018-0896-5
Sacco, Simona ; Merki-Feld, Gabriele S. ; Ægidius, Karen Lehrmann ; Bitzer, Johannes ; Canonico, Marianne ; Gantenbein, Andreas R. ; Kurth, Tobias ; Lampl, Christian ; Lidegaard, Øjvind ; Anne Macgregor, E. ; Maassenvandenbrink, Antoinette ; Mitsikostas, Dimos Dimitrios ; Nappi, Rossella Elena ; Ntaios, George ; Paemeleire, Koen ; Sandset, Per Morten ; Terwindt, Gisela Marie ; Vetvik, Kjersti Grøtta ; Martelletti, Paolo. / Effect of exogenous estrogens and progestogens on the course of migraine during reproductive age : A consensus statement by the European Headache Federation (EHF) and the European Society of Contraception and Reproductive Health (ESCRH). In: Journal of Headache and Pain. 2018 ; Vol. 19, No. 1.
@article{fe66c21327814502bcc57681b5115126,
title = "Effect of exogenous estrogens and progestogens on the course of migraine during reproductive age: A consensus statement by the European Headache Federation (EHF) and the European Society of Contraception and Reproductive Health (ESCRH)",
abstract = "We systematically reviewed data about the effect of exogenous estrogens and progestogens on the course of migraine during reproductive age. Thereafter a consensus procedure among international experts was undertaken to develop statements to support clinical decision making, in terms of possible effects on migraine course of exogenous estrogens and progestogens and on possible treatment of headache associated with the use or with the withdrawal of hormones. Overall, quality of current evidence is low. Recommendations are provided for all the compounds with available evidence including the conventional 21/7 combined hormonal contraception, the desogestrel only oral pill, combined oral contraceptives with shortened pill-free interval, combined oral contraceptives with estradiol supplementation during the pill-free interval, extended regimen of combined hormonal contraceptive with pill or patch, combined hormonal contraceptive vaginal ring, transdermal estradiol supplementation with gel, transdermal estradiol supplementation with patch, subcutaneous estrogen implant with cyclical oral progestogen. As the quality of available data is poor, further research is needed on this topic to improve the knowledge about the use of estrogens and progestogens in women with migraine. There is a need for better management of headaches related to the use of hormones or their withdrawal.",
keywords = "Contraception, Estrogens, Headache, Hormonal contraceptives, Migraine, Progestogens",
author = "Simona Sacco and Merki-Feld, {Gabriele S.} and {\AE}gidius, {Karen Lehrmann} and Johannes Bitzer and Marianne Canonico and Gantenbein, {Andreas R.} and Tobias Kurth and Christian Lampl and {\O}jvind Lidegaard and {Anne Macgregor}, E. and Antoinette Maassenvandenbrink and Mitsikostas, {Dimos Dimitrios} and Nappi, {Rossella Elena} and George Ntaios and Koen Paemeleire and Sandset, {Per Morten} and Terwindt, {Gisela Marie} and Vetvik, {Kjersti Gr{\o}tta} and Paolo Martelletti",
year = "2018",
month = "8",
day = "31",
doi = "10.1186/s10194-018-0896-5",
language = "English",
volume = "19",
journal = "Journal of Headache and Pain",
issn = "1129-2369",
publisher = "BioMed Central Ltd.",
number = "1",

}

TY - JOUR

T1 - Effect of exogenous estrogens and progestogens on the course of migraine during reproductive age

T2 - A consensus statement by the European Headache Federation (EHF) and the European Society of Contraception and Reproductive Health (ESCRH)

AU - Sacco, Simona

AU - Merki-Feld, Gabriele S.

AU - Ægidius, Karen Lehrmann

AU - Bitzer, Johannes

AU - Canonico, Marianne

AU - Gantenbein, Andreas R.

AU - Kurth, Tobias

AU - Lampl, Christian

AU - Lidegaard, Øjvind

AU - Anne Macgregor, E.

AU - Maassenvandenbrink, Antoinette

AU - Mitsikostas, Dimos Dimitrios

AU - Nappi, Rossella Elena

AU - Ntaios, George

AU - Paemeleire, Koen

AU - Sandset, Per Morten

AU - Terwindt, Gisela Marie

AU - Vetvik, Kjersti Grøtta

AU - Martelletti, Paolo

PY - 2018/8/31

Y1 - 2018/8/31

N2 - We systematically reviewed data about the effect of exogenous estrogens and progestogens on the course of migraine during reproductive age. Thereafter a consensus procedure among international experts was undertaken to develop statements to support clinical decision making, in terms of possible effects on migraine course of exogenous estrogens and progestogens and on possible treatment of headache associated with the use or with the withdrawal of hormones. Overall, quality of current evidence is low. Recommendations are provided for all the compounds with available evidence including the conventional 21/7 combined hormonal contraception, the desogestrel only oral pill, combined oral contraceptives with shortened pill-free interval, combined oral contraceptives with estradiol supplementation during the pill-free interval, extended regimen of combined hormonal contraceptive with pill or patch, combined hormonal contraceptive vaginal ring, transdermal estradiol supplementation with gel, transdermal estradiol supplementation with patch, subcutaneous estrogen implant with cyclical oral progestogen. As the quality of available data is poor, further research is needed on this topic to improve the knowledge about the use of estrogens and progestogens in women with migraine. There is a need for better management of headaches related to the use of hormones or their withdrawal.

AB - We systematically reviewed data about the effect of exogenous estrogens and progestogens on the course of migraine during reproductive age. Thereafter a consensus procedure among international experts was undertaken to develop statements to support clinical decision making, in terms of possible effects on migraine course of exogenous estrogens and progestogens and on possible treatment of headache associated with the use or with the withdrawal of hormones. Overall, quality of current evidence is low. Recommendations are provided for all the compounds with available evidence including the conventional 21/7 combined hormonal contraception, the desogestrel only oral pill, combined oral contraceptives with shortened pill-free interval, combined oral contraceptives with estradiol supplementation during the pill-free interval, extended regimen of combined hormonal contraceptive with pill or patch, combined hormonal contraceptive vaginal ring, transdermal estradiol supplementation with gel, transdermal estradiol supplementation with patch, subcutaneous estrogen implant with cyclical oral progestogen. As the quality of available data is poor, further research is needed on this topic to improve the knowledge about the use of estrogens and progestogens in women with migraine. There is a need for better management of headaches related to the use of hormones or their withdrawal.

KW - Contraception

KW - Estrogens

KW - Headache

KW - Hormonal contraceptives

KW - Migraine

KW - Progestogens

UR - http://www.scopus.com/inward/record.url?scp=85052734880&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85052734880&partnerID=8YFLogxK

U2 - 10.1186/s10194-018-0896-5

DO - 10.1186/s10194-018-0896-5

M3 - Article

AN - SCOPUS:85052734880

VL - 19

JO - Journal of Headache and Pain

JF - Journal of Headache and Pain

SN - 1129-2369

IS - 1

M1 - 76

ER -